Parcourir par auteur "Papachristou, E."
Voici les éléments 1-3 de 3
-
Catalytic Inhibition of Eukaryotic Topoisomerases I and II by Flavonol Glycosides Extracted from Vicia faba and Lotus edulis
Tselepi, M.; Papachristou, E.; Emmanouilidi, A.; Angelis, A.; Aligiannis, N.; Skaltsounis, A. L.; Kouretas, D.; Liadaki, K. (2011)Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds ... -
Dose Escalation of Amifostine for Radioprotection During Pelvic Accelerated Radiotherapy
Koukourakis, M. I.; Kyrgias, G.; Panteliadou, M.; Papadopoulou, A.; Tsiarkatsi, M.; Papachristou, E.; Bebeli, M. (2013)Objectives: Experimental data suggest a dose-dependent efficacy of amifostine so that the low overall doses used in clinical trials may have masked the full potential of the drug. In this study, we report our experience ... -
QUALITY OF LIFE, PATIENTS' PREFERENCES AND INFORMED DECISION IN TREATING RHEUMATOID ARTHRITIS IN GREECE
Karageorgopoulou, K.; Seretis, G.; Papachristou, E.; Antoniadis, C.; Aslanidis, S.; Boki, K.; Boura, P.; Boumpas, D.; Ioakeimidis, D.; Kandili, A.; Sakkas, L.; Settas, L.; Solioti, F.; Tzanakakis, M.; Tzioufas, A.; Vassilopoulos, D.; Tountas, Y. (2010)